Home » Newsletters » BioWorld Science

BioWorld Science

July 2, 2012

View Archived Issues

New S1P1 receptor ligands presented by researchers at Allergan

Fixed-dose combination drug evaluated in seasonal allergic and chronic rhinitis

Preclinical and phase I results presented for MLN-4924

First-in-human data presented on PD-1-targeted cancer immunotherapy

Otsuka and Kyowa Hakko Kirin to form strategic alliance

FAS-specific antibody for arthritis shows promise in first clinical trial

Multiple early-stage trials of MLN-9708 presented

OSI Pharmaceuticals divulges novel focal adhesion kinase inhibitors

German company discloses new muteins of human lipocalin

Marshall Edwards changes name

Janssen completes acquisition

Somatuline approved in Japan

New agents for hypercholesterolemia designed in Japan

Gilead submits NDA to FDA for AIDS drug

Pfizer patents novel kynurenine aminotransferase II inhibitors

Scientists at Biomay report new hypoallergenic vaccines

Novel antiviral agents developed

GABA(A) receptor modulator improves sleep in human model of insomnia

Laurantis Pharma presents phase I data on eye drop therapy

GSK and Theravance report on phase III COPD trials

Affymetrix expands product portfolio with acquisition

Japanese phase I study of SO-1105 complete

Bristol-Myers Squibb plans acquisition

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...